CA Patent

CA2136288A1 — Imidazopyridazines

Assigned to Merck Patent GmbH · Expires 1995-05-24 · 31y expired

What this patent protects

Novel imidazopyridazine derivatives of formula I I wherein R is and R1, R2, R3, X and Y are as defined in Patent Claim 1, and their salts, exhibit antagonistic properties towards angiotensin II and can be used for the treatment of hypertension, aldos…

USPTO Abstract

Novel imidazopyridazine derivatives of formula I I wherein R is and R1, R2, R3, X and Y are as defined in Patent Claim 1, and their salts, exhibit antagonistic properties towards angiotensin II and can be used for the treatment of hypertension, aldosteronism, cardiac insufficiency and increased intraocular pressure, and of disorders of the central nervous system.

Drugs covered by this patent

Patent Metadata

Patent number
CA2136288A1
Jurisdiction
CA
Classification
—
Expires
1995-05-24
Drug substance claim
No
Drug product claim
No
Assignee
Merck Patent GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.